Outcome of patients with early stage lung cancer
Tóm tắt
A study was conducted to evaluate the outcomes of 79 patients with early stage lung cancer diagnosed according to the following criteria. Central tumors were located in the segmental bronchi, or more proximally, and tumor invasion was limited to the bronchial wall without lymph node or distant metastases. Peripheral tumors were located distal to the subsegmental bronchi and were less than 2 cm in greatest dimension, and invasion was limited to the visceral pleura, with no lymph node or distant metastases. The 5-year survival rate was 100% for patients with peripheral type early squamous cell carcinoma, 94.6% for those with central-type early squamous cell carcinoma, and 79.3% for those with early adenocarcinoma. The 5-year survival rate for patients with central-type squamous cell carcinoma without pericartilage layer invasion was 97.0%, and that for those with T1N0M0 peripheral squamous cell carcinoma was 100.0%. To define early stage lung cancer as curable, it should be defined as T1N0M0, peripheral squamous cell carcinoma, or central squamous cell carcinoma without pericartilage layer invasion. For other histologic types, some added parameters are needed. The rate of multiple lung cancers was 10.1% and that of multiple primary malignant disease was 13.9%. Thus, careful followup of patients with early stage lung cancer should be carried out, as second malignancies in the lung and elsewhere are commonly detected.
Tài liệu tham khảo
Health and Welfare Statistics Association (1996) Koseinoshihyou, Kokumin eiseino doukou (in Japanese) 43:42–74
Japanese Ministry of Health and Welfare (1972, 1975, 1979) Annual Reports on Cancer Research. Japanese Ministry of Health and Welfare, Tokyo
Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. M Stat Assoc J 53:457–481
Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 52:203–223
Warren S, Gates O (1932) Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer 16:1358–1414
Martini N, Melamed MR (1975) Multiple primary lung cancers. J Thorac Cardiovasc Surg 70:606–611
Hayata Y, Kato H, Konaka C, Amemiya R, Ono J, Ogawa I, Kinoshita K, Sakai H, Takahashi H (1984) Photoradiation therapy with hematoporphyrin derivative in early and stage I lung cancer. Chest 86:169–177
Shimosato Y, Susuki A, Hashimoto H, Nishiwaki Y, Kodama T, Yoneyama T, Kameya T (1980) Prognostic implications of fiblotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 4:365–373
Kurokawa T, Matsuno Y, Noguchi M, Mizuno S, Shimosato Y (1994) Surgically curable “early” adenocarcinoma in the periphery of the lung. Am J Surg Pathol 18:431–438
Yamaguchi Y (1986) Haigan Geka Shinryou Saizensen (in Japanese). Kanehara, Tokyo, pp 18–19
Watanabe Y, Shimizu J, Oda M, Iwai T, Takashima T, Kamimura R, Kitagawa M, Nonomura A, Nakamura S, Tanimoto K, Matsubara F, Ikegami S, Yamada K (1991) Early hilar lung cancer: its clinical aspect. J Surg Oncol 48:75–80
Woolner LB, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, Pairolero PC, Piehler JM, Taylor WF (1984) Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 59:453–466